Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/07/24
Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual MeetingPRNewsWire • 11/07/24
Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in AlabamaPRNewsWire • 11/04/24
Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial MarketsPRNewsWire • 10/31/24
Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin DiseasesPRNewsWire • 10/29/24
Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic LeukemiaPRNewsWire • 10/17/24
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024PRNewsWire • 09/25/24
Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial MarketsPRNewsWire • 08/01/24
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024PRNewsWire • 06/12/24
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial MarketsPRNewsWire • 05/02/24
Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune DiseasesGlobeNewsWire • 04/24/24
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 04/03/24
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual ConferencePRNewsWire • 03/22/24